Success Metrics

Clinical Success Rate
95.2%

Based on 20 completed trials

Completion Rate
95%(20/21)
Active Trials
9(23%)
Results Posted
20%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph early_phase_1
3
8%
Ph phase_2
19
48%
Ph not_applicable
7
18%
Ph phase_1
9
23%
Ph phase_4
2
5%

Phase Distribution

12

Early Stage

19

Mid Stage

2

Late Stage

Phase Distribution40 total trials
Early Phase 1First-in-human
3(7.5%)
Phase 1Safety & dosage
9(22.5%)
Phase 2Efficacy & side effects
19(47.5%)
Phase 4Post-market surveillance
2(5.0%)
N/ANon-phased studies
7(17.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.2%

20 of 21 finished

Non-Completion Rate

4.8%

1 ended early

Currently Active

9

trials recruiting

Total Trials

40

all time

Status Distribution
Active(13)
Completed(20)
Terminated(1)
Other(6)

Detailed Status

Completed20
Recruiting9
unknown6
Not yet recruiting4
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
40
Active
9
Success Rate
95.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (7.5%)
Phase 19 (22.5%)
Phase 219 (47.5%)
Phase 42 (5.0%)
N/A7 (17.5%)

Trials by Status

not_yet_recruiting410%
terminated13%
unknown615%
recruiting923%
completed2050%

Recent Activity

Clinical Trials (40)

Showing 20 of 40 trialsScroll for more
NCT06194851Phase 2

Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD

Recruiting
NCT04218409Early Phase 1

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

Recruiting
NCT07162584Not Applicable

Oxytocin and Human Defensive Responses in a Dynamic Situation

Recruiting
NCT06808516Phase 2

Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Recruiting
NCT04551482Phase 2

Oxytocin for Weight Loss in Adolescents

Recruiting
NCT06945926Phase 2

The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery

Not Yet Recruiting
NCT06676774Phase 2

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

Recruiting
NCT06199076Phase 2

Experimental Study on Alcohol Use and Behavior in Young Adults

Terminated
NCT05760807Not Applicable

Intranasal Oxytocin for Methamphetamine Withdrawal in Women

Completed
NCT06881810Phase 2

Enhancing Social Skills in Schizophrenia Spectrum Disorders - Oxytocin as add-on to Psychosocial Treatment

Recruiting
NCT03245437Phase 4

Target Engagement and Response to Oxytocin

Completed
NCT06757517Phase 2

Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT

Recruiting
NCT05968651Phase 2

Social Safety Learning in the Brain Oxytocin System

Completed
NCT06248710Phase 2

Dog Presence and Oxytocin on Trust Towards Therapists

Recruiting
NCT05934812Phase 2

Intranasal Oxytocin in Youth With Autism

Not Yet Recruiting
NCT04071119Phase 1

Alcohol and Cigarette Craving During Oxytocin Treatment

Completed
NCT03136263Early Phase 1

Oxytocin and Cognitive Control in Adult ADHD

Completed
NCT05093296Phase 2

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

Completed
NCT06332066Phase 1

Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness

Not Yet Recruiting
NCT04732247Phase 2

Oxytocin for Oxidative Stress and Inflammation

Completed

Drug Details

Intervention Type
DRUG
Total Trials
40